EN
UnionClin has recently signed a Master Service Agreement (MSA) with MEDSIR, a leading oncology-focused CRO headquartered in Spain. The two companies have established a strategic partnership and launched full collaboration in international multi-center clinical development services.
As the Spring Equinox marks the start of a new year, 2025 witnessed a quiet yet pivotal shift in China’s innovative pharmaceutical sector. With the industry’s hype fading, the focus has converged on a core question: how to generate denser, more reliable clinical evidence – a priority that outweighs chasing fleeting technological trends.
Official WeChat
